Compile Data Set for Download or QSAR
Report error Found 225 Enz. Inhib. hit(s) with Target = 'Solute carrier family 13 member 5'
TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610822(US10626095, Example 130)
Affinity DataEC50:  730nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610823(US10626095, Example 131)
Affinity DataEC50:  440nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610825(US10626095, Example 132)
Affinity DataEC50:  320nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610826(US10626095, Example 133)
Affinity DataEC50:  190nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610828(US10626095, Example 134)
Affinity DataEC50:  85nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610829(US10626095, Example 135)
Affinity DataEC50:  1.57E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610830(US10626095, Example 136)
Affinity DataEC50:  680nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610831(US10626095, Example 137)
Affinity DataEC50:  570nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610832(US10626095, Example 138)
Affinity DataEC50:  62nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610834(US10626095, Example 139)
Affinity DataEC50:  210nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610835(US10626095, Example 140)
Affinity DataEC50:  800nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610836(US10626095, Example 141)
Affinity DataEC50:  710nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610837(US10626095, Example 142)
Affinity DataEC50:  580nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610838(US10626095, Example 143)
Affinity DataEC50:  1.02E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610840(US10626095, Example 144)
Affinity DataEC50:  790nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610841(US10626095, Example 145)
Affinity DataEC50:  370nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610842(US10626095, Example 146)
Affinity DataEC50:  410nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610843(US10626095, Example 147)
Affinity DataEC50:  1.66E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610844(US10626095, Example 148)
Affinity DataEC50:  920nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610845(US10626095, Example 149)
Affinity DataEC50:  700nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610846(US10626095, Example 150)
Affinity DataEC50:  860nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610847(US10626095, Example 220)
Affinity DataEC50:  350nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610848(US10626095, Example 275)
Affinity DataEC50:  1.04E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610849(US10626095, Example 276)
Affinity DataEC50:  850nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610850(US10626095, Example 298)
Affinity DataEC50:  740nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610851(US10626095, Example 423)
Affinity DataEC50:  920nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610852(US10626095, Example 504)
Affinity DataEC50:  1.47E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610853(US10626095, Example 600)
Affinity DataEC50:  430nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610854(US10626095, Example 607)
Affinity DataEC50:  450nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610855(US10626095, Example 610)
Affinity DataEC50:  1.74E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610856(US10626095, Example 613)
Affinity DataEC50:  430nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610857(US10626095, Example 617)
Affinity DataEC50:  480nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610858(US10626095, Example 620)
Affinity DataEC50:  1.45E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610859(US10626095, Example 623)
Affinity DataEC50:  690nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610860(US10626095, Example 627)
Affinity DataEC50:  740nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610861(US10626095, Example 639)
Affinity DataEC50:  1.21E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610862(US10626095, Example 640)
Affinity DataEC50:  670nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610863(US10626095, Example 644)
Affinity DataEC50:  2.35E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610864(US10626095, Example 645)
Affinity DataEC50:  1.09E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610865(US10626095, Example 646)
Affinity DataEC50:  620nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610866(US10626095, Example 649)
Affinity DataEC50:  2.47E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610868(US10626095, Example 657)
Affinity DataEC50:  1.16E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610869(US10626095, Example 659)
Affinity DataEC50:  810nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610870(US10626095, Example 663)
Affinity DataEC50:  1.25E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610871(US10626095, Example 718)
Affinity DataEC50:  1.51E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610872(US10626095, Example 790)
Affinity DataEC50:  980nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610873(US10626095, Example 807)
Affinity DataEC50:  1.10E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610875(US10626095, Example 931)
Affinity DataEC50:  690nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610876(US10626095, Example 934)
Affinity DataEC50:  510nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610877(US10626095, Example 944)
Affinity DataEC50:  1.01E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 225 total ) | Next | Last >>
Jump to: